Clinical Trial Update: Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating aripiprazole for behavioral symptoms in children and adolescents with autism completed, with results posted in July 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Abilify (aripiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Behavioral Symptoms, Autistic Disorder | Phase 3 | Status: COMPLETED | Results posted: 2009-07-23